Top 10 Pharmaceuticals markets in Hong KongThe fastest-growing and largest of the 20 sized Pharmaceuticals markets in Hong Kong, 2023 to 2033, with active clinical trials.
| # | Market | 2023 | 2033 (projected) | CAGR | Active trials |
|---|---|---|---|---|---|
| 1 | Biosimilars | $59 Mn | $592 Mn | 25.9% | 7 |
| 2 | Cell Based Immunotherapy | $27 Mn | $229 Mn | 24% | 251 |
| 3 | Cannabidiol (CBD) | $35 Mn | $182 Mn | 17.8% | 3 |
| 4 | Cannabis | $54 Mn | $210 Mn | 14.5% | 3 |
| 5 | Atopic Dermatitis Drugs | $18 Mn | $62 Mn | 13.2% | 5 |
| 6 | Oncology/Cancer Drugs | $284 Mn | $697 Mn | 9.4% | 300 |
| 7 | Anti-Aging | $141 Mn | $338 Mn | 9.1% | 36 |
| 8 | Diabetes Management | $125 Mn | $272 Mn | 8.1% | 40 |
| 9 | Alzheimer Drugs | $8 Mn | $17 Mn | 7.8% | 9 |
| 10 | Contraceptives Drugs | $40 Mn | $86 Mn | 7.8% | 1 |
| # | Market | 2023 | 2033 (projected) | CAGR | Active trials |
|---|---|---|---|---|---|
| 1 | Oncology/Cancer Drugs | $284 Mn | $697 Mn | 9.4% | 300 |
| 2 | Anti-Aging | $141 Mn | $338 Mn | 9.1% | 36 |
| 3 | Diabetes Management | $125 Mn | $272 Mn | 8.1% | 40 |
| 4 | Gastrointestinal Drugs | $87 Mn | $149 Mn | 5.6% | 160 |
| 5 | Asthma & COPD Drugs | $79 Mn | $129 Mn | 5% | 20 |
| 6 | Biosimilars | $59 Mn | $592 Mn | 25.9% | 7 |
| 7 | Cannabis | $54 Mn | $210 Mn | 14.5% | 3 |
| 8 | HIV Drugs | $48 Mn | $93 Mn | 6.8% | 8 |
| 9 | Contraceptives Drugs | $40 Mn | $86 Mn | 7.8% | 1 |
| 10 | Cancer Supportive Care Drugs | $40 Mn | $69 Mn | 5.7% | 61 |
2033 values are projected from the 2023 size and the CAGR. Each market name opens its report. Active trials: recruiting, about to start or running.
Biosimilars grows fastest, at 25.9% a year from 2023 to 2033, ahead of Cell Based Immunotherapy (24%).
Oncology/Cancer Drugs is the largest, worth about $284 Mn in 2023 and $697 Mn by 2033 (projected).
Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov (fetched 10 Nov 2026); found by search words, so counts are a guide.
China
India
Japan
Australia
Philippines
Singapore
Thailand
Malaysia